References
- World Health Organization. Fact sheet N°102 – lymphatic filariasis. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/ [last accessed 6 Nov 2016].
- Mackenzie CD, Geary TG. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Expert Rev Anti Infect Ther 2011;9:497–501.
- Mackenzie CD, Geary TG, Gerlach JA. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J 2003;2:S5.
- Dominguez-Vazquez A, Taylor HR, Greene BM, et al. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet 1983;1:139–43.
- Goodwin LG. Chemotherapy. Trans R Soc Trop Med Hyg 1984;78:1–8.
- Naicker S, Plange-Rhule J, Tutt RC, Eastwood JB. Shortage of healthcare workers in developing countries – Africa. Ethn Dis 2009;19:S1-60–64.
- Dicko M, Oni A-QO, Ganivet S, et al. Safety of immunization injections in Africa: not simply a problem of logistics. Bull World Health Organ 2000;78:163–9.
- Vialpando M, Smulders S, Bone S, et al. Evaluation of three amorphous drug delivery technologies to improve the oral absorption of flubendazole. J Pharm Sci 2016;105:2782–93.
- Ceballos L, Elissondo M, Bruni SS, Denegri G, Alvarez L, Lanusse C. Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice. Parasitol Int 2009;58:354–8.
- Balogh A, Horváthová T, Fülöp Z, et al. Electroblowing and electrospinning of fibrous diclofenac sodium-cyclodextrin complex-based reconstitution injection. J Drug Deliv Sci Technol 2015;26:28–34.
- Nagy ZK, Wagner I, Suhajda Á, et al. Nanofibrous solid dosage form of living bacteria prepared by electrospinning. eXPRESS Polym Lett 2014;8:352–61.
- Sóti PL, Nagy Z, Serneels K, et al. Preparation and comparison of spray dried and electrospun bioresorbable drug delivery systems. Eur Polym J 2015;68:671–9.
- Nagy Z, Nyúl K, Wagner K, et al. Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl. Express Polym Lett 2010;4:763–72.
- Nagy ZK, Balogh A, Vajna B, et al. Comparison of electrospun and extruded soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 2012;101:322–32.
- Yu DG, Zhu L, White M, Branford-White KC. Electrospun nanofiber-based drug delivery systems. Health 2009;1:67–75.
- Yu D-G, Zhang X-F, Shen X-X, et al. Ultrafine ibuprofen-loaded polyvinylpyrrolidone fiber mats using electrospinning. Polym Int 2009;58:1010–13.
- Vigh T, Horváthová T, Balogh A, et al. Polymer-free and polyvinylpirrolidone-based electrospun solid dosage forms for drug dissolution enhancement. Eur J Pharm Sci 2013;49:595–602.
- Balogh A, Drávavölgyi G, Faragó K, et al. Plasticized drug-loaded melt electrospun polymer mats: characterization, thermal degradation, and release kinetics. J Pharm Sci 2014;103:1278–87.
- Balogh A, Farkas B, Faragó K, et al. Melt-blown and electrospun drug-loaded polymer fiber mats for dissolution enhancement: a comparative study. J Pharm Sci 2015;104:1767–76.
- Panthi G, Park M, Kim H-Y, Park S-J. Electrospun polymeric nanofibers encapsulated with nanostructured materials and their applications: a review. J Ind Eng Chem 2015;24:1–13.
- Ghorani B, Tucker N. Fundamentals of electrospinning as a novel delivery vehicle for bioactive compounds in food nanotechnology. Food Hydrocoll 2015;51:227–40.
- Sell SA, McClure M, Garg JK, et al. Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering. Adv Drug Deliv Rev 2009;61:1007–19.
- Reneker DH, Yarin A, Zussman L, Xu EH. Electrospinning of nanofibers from polymer solutions and melts. Adv Appl Mech 2007;41:43–346.
- Agarwal S, Greiner A, Wendorff JH. Functional materials by electrospinning of polymers. Prog Polym Sci 2013;38:963–91.
- Reneker DH, Yarin AL. Electrospinning jets and polymer nanofibers. Polymer 2008;49:2387–425.
- Brettmann B, Cheng KK, Myerson AS, Trout BL. Electrospun formulations containing crystalline active pharmaceutical ingredients. Pharm Res 2013;30:238–46.
- Raimi-Abraham B, Mahalingam TS, Davies P, et al. Development and characterization of amorphous nanofiber drug dispersions prepared using pressurized gyration. Mol Pharm 2015;12:3851–61.
- Molnar K, Nagy ZK. Corona-electrospinning: needleless method for high-throughput continuous nanofiber production. Eur Polym J 2016;74:279–86.
- Nagy ZK, Balogh A, Démuth B, et al. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole. Int J Pharm 2015;480:137–42.
- Vanhoorne V, Bekaert B, Peeters E, et al. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation. Int J Pharm 2016;506:13–24.
- Peeters E, Tavares da Silva A, Toiviainen F, et al. Assessment and prediction of tablet properties using transmission and backscattering Raman spectroscopy and transmission NIR spectroscopy. Asian J Pharm Sci 2016;11:547–58.
- Leister D. Continuous granulation - opportunities to increase efficiency in pharmaceutical production. Pharma Bio World July 2011;42–46.
- Démuth B, Nagy Z, Balogh K, et al. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. Int J Pharm 2015;486:268–86.
- Grabowski T, Jaroszewski J, Piotrowski JW. Correlations between no observed effect level and selected parameters of the chemical structure for veterinary drugs. Toxicol Vitr 2010;24:953–9.
- Lampo A, Vanparys P, van Cauteren H. Report on the safety documentation of flubendazole. A report written at Janssen Research Foundation, Beerse, 1996.
- Ceballos L, Moreno L, Torrado JJ, et al. Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution. BMC Vet Res 2012;8:71–80.
- Nobilis M, Jira T, Lísa M, et al. Achiral and chiral high-performance liquid chromatographic determination of flubendazole and its metabolites in biomatrices using UV photodiode-array and mass spectrometric detection. J Chromatogr A 2007;1149:112–20.
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Tripartite Guideline – Impurities: Guideline for Residual Solvents, Q3C(R5). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3C/Step4/Q3C_R5_Step4.pdf [last accessed 15 Mar 2015].
- Bull LS, Pitts GC. Gastric capacity and energy absorption in the force-fed rat. J Nutr 1971;101:593–6.
- Altman PL, Dittmer DS. Blood and other body fluids. In: Biological handbooks. Washington, DC: Federation of American Societies for Experimental Biology; 1961. p. 186.
- Nebendahl K. Routes of administration. The laboratory rat. Elsevier; 2000:463–483.
- Zahner H, Schares G. Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Trop 1993;52:221–66.